Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. Esophageal cancer is cancer arising from the esophagus which is the food pipe connecting the throat and the stomach. The two main sub-types of esophageal cancer are esophageal squamous-cell carcinoma which arises from the epithelial cells and esophageal adenocarcinoma which arises from the glandular cells. These two cancers have different primary causes and different rates of prevalence. Esophageal squamous-cell carcinoma is more common in the developing world, and esophageal adenocarcinoma is more common in the developed world. Esophageal cancer makes up about 1% of all cancers diagnosed in the United States. It is much more common in Asian regions of Iran, China, and India etc. Considering all these factors the market for esophageal cancer is expected to reach $1000.1 million by the end of 2023, this market is projected to growing at a CAGR of ~ 8.7 % during 2017-2023.
Esophageal squamous-cell carcinoma accounts for the largest proportion of Esophageal cancer. According to the American Cancer Society in 2017 the esophageal cancer rate in the United States was about 16,940 cases diagnosed resulting in 15,690 deaths. The disease is also 3 to 4 times more common among men than women.
The survival rate for 5 years after diagnosis is about 20% of patients. Survival rates depend on many factors such as stage of cancer, health of patient etc.
Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/3280
Key players of Global Esophageal cancer Market:
• Eli Lilly and Company,
• F. Hoffmann-La Roche,
• Bristol-Myers Squibb Company,
• Boehringer Ingelheim GmbH,
• Bristol-Myers Squibb,
• GlaxoSmithKline Plc.,
• Novartis AG,
• Johnson & Johnson,
• Gilead Sciences,
• Merck & Co.
Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Esophageal Cancer Market Research Report- Global Forecast To 2023”
The global Esophageal cancer market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III.
Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors.
Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Global esophageal cancer market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America leads the global market for Esophageal cancer which is led by the U.S. The reasons for the dominance of U.S. is the high per capita income of U.S., the faster uptake of new technology, the better reimbursement than other countries etc. The large share is also attributed to technology advanced healthcare market in the region, increasing development in cancer biological and targeted therapy treatment. US also has multiple large companies which are involved in the development of esophageal cancer business.
Browse full report @ https://www.marketresearchfuture.com/reports/esophageal-cancer-market-3280
Table of Content
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5 Global Esophageal Cancer Market, By Type
Global Liquid chromatography Instruments Market Information by Type (High pressure liquid chromatography, Liquid-solid chromatography, Chiral chromatography), by End User (pharmaceuticals, Hospitals, research laboratories) – Forecast to 2027.Know more about this report @ https://www.marketresearchfuture.com/reports/liquid-chromatography-instruments-market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312